M&A Deal Summary

Abbott Laboratories Acquires Piramal Healthcare Generic Drugs

On May 26, 2010, Abbott Laboratories acquired life science company Piramal Healthcare Generic Drugs from Piramal Enterprises for 3.7B USD

Acquisition Highlights
  • This is Abbott Laboratories’ 9th transaction in the Life Science sector.
  • This is Abbott Laboratories’ 6th largest (disclosed) transaction.
  • This is Abbott Laboratories’ 1st transaction in India.

M&A Deal Summary
Date 2010-05-26
Target Piramal Healthcare Generic Drugs
Sector Life Science
Buyer(s) Abbott Laboratories
Sellers(s) Piramal Enterprises
Deal Type Add-on Acquisition
Deal Value 3.7B USD

Target

Piramal Healthcare Generic Drugs

India
Piramal Healthcare Generic Drugs is the generic drug unit of Piramal Healthcare.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 21 of 35
Sector (Life Science) 9 of 11
Type (Add-on Acquisition) 21 of 35
Country (India) 1 of 1
Year (2010) 3 of 4
Size (of disclosed) 6 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-09 Facet Biotech

Redwood City, California, United States

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of five clinical-stage products focused in multiple sclerosis and oncology, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics.

Buy $450M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-01 Abbott Laboratories S.A.

Madrid, Spain

Abbott Laboratories, S.A. (Spain) produces solid dose, sterile ointments, oral liquids, aerosols and topical products.

Sell -

Seller(S) 1

SELLER

Piramal Enterprises

Mumbai, India
Category Company
Founded 1947
Sector Healthcare Services
Employees3,000
Revenue 81.1B INR (2024)
DESCRIPTION

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, India.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 1
Country (India) 1 of 2
Year (2010) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-22 Bharat Serums And Vaccines Anesthetic products

India

Bharat Serums And Vaccines injectible anesthetic products business comprises , Propofol, Bupivacaine and Atracurium Besylate. This anesthetic product range is developed and currently manufactured by BSV at its own plant.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-05-16 Decision Resources

Burlington, Massachusetts, United States

Decision Resources LLC is a provider of research publications, advisory services, and consulting services to help clients shape strategy, allocate resources, and master their chosen markets. Decision Resources was formed in 1990 and is based in Burlington, Massachusetts.

Buy $635M
Mergr

Product

Company

Legal